Medicines & drug development

Which drugs are most suitable for which patient? Which combinations of drugs work best? Can drugs be more afforable? Read about our latest activities and insights here,

February 22, 2023
The Methotrexate Monitoring trial Renske Hebing was awarded the AII Extension Grant in 2021 for her research proposal “Pharmacokinetics of Oral and Subcutaneous Methotrexate in Red and White Blood Cells in Patients with Early Rheumatoid Arthritis – the Methotrexate Monitoring Trial (MeMo study)”. Recently, Renske’s article was published in the Annals of the Rheumatic Diseases (ARD).
- Medicines & drug development
October 24, 2022
Grant awarded: clinical trial anti-inflammatory drug for Sjögren's syndrome A grant of 200,000 euros has been awarded to Dr. Derk Jan Jager and colleagues to set up a study on the safety and efficacy of a drug (AZD9056) for patients with Sjögren’s syndrome. This study will examine whether the drug is able to preserve the function of the salivary glands in patients with Sjögren's syndrome.
- Medicines & drug development
May 30, 2022
Winning combination of drugs for treating Chronic Lymphocytic Leukemia Patients with Chronic Lymphocytic Leukemia (CLL) are better off with a combination of ibrutinib and venetoclax. This is more effective than the standard treatment, researchers of Amsterdam UMC discovered.
November 26, 2021
Good Use of Medicines grant for research group of Jeroen Hermanides The grant will be used to investigate the use of SGLT-2 inhibitors in cardiac surgery.
- Awards, grants & gifts
- Medicines & drug development
November 24, 2021
Reviewing the Alzheimer’s drug development landscape Pieter van Bokhoven and colleagues looked into the landscape of the Alzheimer’s disease drug development. This review gives insight into the status of AD drug development by comparing drugs in preclinical development to drugs currently tested in clinical trials.
- Age & Alzheimer
- Medicines & drug development
November 12, 2021
Ultra-modern imaging facilities bring together clinical care, research and drug development Amsterdam UMC’s Imaging Center offers required technical facilities to provide a good diagnostic picture, and brings together clinical care, research and drug development under one roof.
- Imaging
- Medicines & drug development
October 27, 2021
Study on tailor-made treatment for MS drug ocrelizumab Given the potential side effects of ocrelizumab, there is a need to investigate whether a personalized treatment regimen is possible. Neurologists Joep Killestein and Zoé van Kempen have been awarded 1.3 million euros by ZonMw and the Treatmeds foundation.
- Brain & Psychiatry
- Medicines & drug development
August 31, 2021
An atlas for treating brain tumors, toxicity mapping by Amsterdam UMC and Medstone Medstone and Amsterdam UMC are joining forces in an ambitious research project, searching for better treatment options for patients with brain cancer. Various specialists are working together in this collaboration between Amsterdam UMC and pharmaceutical company Medstone - from neuro-oncologist to PhD student and data scientist. We asked six of them about the motivation for this multidisciplinary project and the goals they will be working towards during the coming four years
June 9, 2021
Developing new medicines for patients with multiple myeloma Two reports from the research teams of Niels van de Donk, Sonja Zweegman and Tuna Mutis show promising results in laboratory studies with two different antibodies that target multiple myeloma cells.
- Cancer
- Medicines & drug development